TET2-interacting long noncoding RNA promotes active DNA demethylation of the MMP-9 promoter in diabetic wound healing

Cell Death Dis. 2019 Oct 25;10(11):813. doi: 10.1038/s41419-019-2047-6.

Abstract

Wound healing in diabetic skin is impaired by excessive activation of matrix metalloproteinase-9 (MMP-9). MMP-9 transcription is activated by Ten-eleven translocation 2 (TET2), a well-known DNA demethylation protein that induces MMP-9 promoter demethylation in diabetic skin tissues. However, how TET2 is targeted to specific loci in the MMP-9 promoter is unknown. Here, we identified a TET2-interacting long noncoding RNA (TETILA) that is upregulated in human diabetic skin tissues. TETILA regulates TET2 subcellular localization and enzymatic activity, indirectly activating MMP-9 promoter demethylation. TETILA also recruits thymine-DNA glycosylase (TDG), which simultaneously interacts with TET2, for base excision repair-mediated MMP-9 promoter demethylation. Together, our results suggest that the TETILA serves as a genomic homing signal for TET2-mediated demethylation specific loci in MMP-9 promoter, thereby disrupting the process of diabetic skin wound healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Demethylation
  • DNA Methylation / genetics
  • DNA-Binding Proteins / genetics*
  • Diabetes Mellitus / genetics*
  • Diabetes Mellitus / pathology
  • Dioxygenases
  • Humans
  • Matrix Metalloproteinase 9 / genetics*
  • Promoter Regions, Genetic / genetics
  • Proto-Oncogene Proteins / genetics*
  • RNA, Long Noncoding / genetics*
  • Translocation, Genetic
  • Wound Healing / genetics*

Substances

  • DNA-Binding Proteins
  • Proto-Oncogene Proteins
  • RNA, Long Noncoding
  • Dioxygenases
  • TET2 protein, human
  • Matrix Metalloproteinase 9